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Abstract: Zinc phosphide (ZnP) is low-cost, accessible, and very effective as a rodenticide. It has been used for many
human suicide poisonings around the world, including Iran. Nonspecific gastrointestinal symptoms and car-
diotoxicity are the most serious complications of ZnP poisoning, which are associated with a high mortality
rate. The aim of this paper was to report a poisoned patient that ingested ZnP with suicidal attempt and faced
complications due to hemolysis.
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1. Introduction
Zinc phosphide (ZnP) is a metallophosphide, dark grey and
crystalline compound that is commonly used as a rodenti-
cide due to its low cost and ease of availability (1, 2). ZnP poi-
soning could happen accidentally or intentionally as means
of suicidal or homicidal attempts (3). Routes of entry into
the body could be via ingestion, inhalation or through the
skin. The most common clinical symptoms in poisoned
cases include nausea, vomiting, abdominal pain, hypoten-
sion, metabolic acidosis, respiratory alkalosis and acute re-
nal failure (4). Moreover, in some cases, rare complications
such as acute pancreatitis, pulmonary edema, transient hy-
perglycemia, transient leucopenia and intravascular hemol-
ysis may be seen (5-9). In this case report, we report a 37-
year-old male patient who ingested ZnP in order to commit a
suicide and faces complications due to hemolysis.
2. Case report
A 37-year-old man with no significant past medical history
was admitted to emergency ward with a history of acute in-
gestion of 8 packs (about 40 grams) of a dark grey, crystalline
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compound rodenticide in order to commit suicide. On ad-
mission, the patient was lethargic and had nausea, vomit-
ing, abdominal pain and lacrimation with the following vi-
tal signs: blood pressure: 130/80 mmHg, pulse rate: 110
beat/minute, respiratory rate: 22 per minute, temperature:
37◦C and saturation of O2: 92% in room air. The general
physical and neurological examination was not significant.
Supportive therapy was initiated and he underwent gastric
lavage with %0.9 NaCl solution and activated charcoal treat-
ment. Primary results of laboratory tests in emergency de-
partment are shown in Table 1. Full blood count, coagulation
parameters, biochemistry, and urine analysis were in normal
range and mild metabolic acidosis was reported in arterial
blood gas (ABG) analysis. His electrocardiogram (ECG) only
revealed sinus tachycardia.
With the impression of organophosphorus poisoning, treat-
ment with 0.5 mg intravenous Atropine every 5 minutes and
2 grams intravenous pralydoxim every 6 hours was started.
After receiving care for three days, the sclera and skin of
the patient became icteric and nausea and epigastria pain
increased. In Laboratory tests, hemoglobin and platelet had
decreased with normal coagulation parameters (Table 2).
Liver enzymes, serum bilirubin, creatine phosphokinase
(CPK) and lactate dehydrogenase (LDH) had increased. We
started infusion of fresh frozen plasma (FFP) with diag-
nosis of hemolysis and diffuse intravascular coagulation
(DIC). The patient underwent antioxidant therapy with N
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Table 1: Laboratory data of the patient in emergency department
Laboratory parameters Normal range Results Laboratory parameters Normal range Results
BUN (mg/dl) 5-20 17 Platelet count (*103/m3) 150-400 298
Creatinine (mg/dl) 0.5-1.5 0.7 PTT (s) 25–36 s 29
Serum Na (mEq/l) 135-145 143 PT (s) 11–13 s 14.7
Serum K (mEq/l) 3.5-4.5 3.5 INR 1-1.5 1.3
LDH (U/L) 225-500 273 Bilirubin (mg/dl)
CPK (U/L) 20-200 107 Total 0.2–1.3 0.9
Amylase (U/L) 30-100 66 Direct < 0.2 0.2
Blood glucose (mg/dl) 70-110 116 AST (IU/L) 11–47 38
WBC (*103/m3) 4-11 9.6 ALT (IU/L) 7–53 22
RBC (*103/m3) 3.5-5.5 5.4 ALP (IU/L) 38–126 50
Hemoglobin (g/dL) 12.5-17.5 16.8 pH 7.35-7.45 7.33
BUN: Blood Urea Nitrogen; LDH: Lactate dehydrogenase; CPK: Creatinine phosphokinase; WBC: White blood cells; RBC: Red blood cells;
PTT: Partial thromboplastin time; PT: Prothrombin time; INR: International normalized ratio; AST: Aspartate aminotransferase;
ALT: Alanine aminotransferase; ALP: Alkaline phosphatase
Table 2: Serial laboratory results of the patient during hospitalization
Laboratory parameters Normal range 12 hours Day 1 Day 2 Day 3 Day 4
Serum Na 135-145 mEq/l 136 140 138 135 138
Serum K 3.5-4.5 mEq/l 2.9 3.3 3 3.7 4
Lactate dehydrogenase (LDH) 225-500 U/L 370 1325 2471 1840 768
Creatinine phosphokinase (CPK) 20-200 U/L 450 625 706 400 68
White blood cells (WBC) 4-11 *103/m3 6.4 10.1 18.4 10.2 6.6
Red blood cells (RBC) 3.5-5.5 *106/m3 3.8 2.44 3 3.5 4
Hemoglobin 12.5-17.5 g/dL 12.3 7.6 9 10.5 11.8
Platelet count 150-400 *103/m3 209 129 151 168 252
Partial thromboplastin time (PTT) 25–36 s 29 31 29 28 22
Prothrombin time (PT) 11–13 s 14.7 20 16.1 12.7 12.4
International normalized ratio (INR) 1-1.5 1.3 3.9 1.3 1.5 1
Total bilirubin 0.2–1.3 mg/dL 20 31.7 15.5 4.2 3.3
Direct bilirubin </0.2 mg/dL 7.9 20 8.5 2.5 1.9
Aspartate aminotransferase (AST) 11–47 IU/L 200 235 180 60 25
Alanine aminotransferase (ALT) 7–53 IU/L 190 163 131 82 70
Alkaline phosphatase (ALKP) 38–126 IU/L 572 656 429 409 372
pH 7.35-7.45 7.58 7.51 7.45 7.5 7.41
PCO2 33-45 mmHg 32 37.9 38 36.2 35.3
HCO3 22-28 mEq/L 30.8 34.8 35.1 30.9 28.1
acetyl cysteine (NAC) a dose of 150 mg/kg (9 gr) in 200cc
dextrose-water (DW) 5% injected in 15 minutes as load-
ing dose, followed by 50 mg/kg (3 gr) in 500cc DW5% in
4 hours and then 100 mg/kg (6gr) in 1000cc DW5% in 16
hours as maintenance dose. In peripheral blood smear, we
observed platelet aggregation and evidence of disseminated
intravascular coagulation (DIC). We transfused 2 units of
pack cells due to hemoglobin level being 6.4 mg/dl and it
reached 9 mg/dl thereafter. Coagulation parameters also
were corrected after infusion of FFP. On the ninth day of
admission, the patient was stable, Lab tests became normal
and the patient was referred to psychiatry service and was
discharged from toxicology service.
3. Discussion
Phosphides (aluminum, calcium and zinc) have been used
as rodenticides, but they have also been used for suicide at-
tempts, especially in developing countries (10). A dosage of 4
to 5 grams of ZnP (55-70 mg/kg) could result in death due
to acute toxicity in humans (3). The mechanism of action
for ZnP is similar to aluminum phosphide as both produce
toxic hydrogen phosphine (PH3) gas (4). When ingested, it
is hydrolyzed by the gastric acid and transformed into phos-
phine gas, which mixes into the blood stream via the stomach
and intestine vessels (3, 5). Phosphine inhibits cytochrome
C oxidase enzyme in the respiratory chain, which leads to
widespread cellular hypoxia. The direct toxic effect of phos-
phine on the vessel wall produces bleeding diathesis, which
may lead to hemorrhage in the gastrointestinal tract, eyes
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and extremities (11).
Clinical symptoms are severe hypotension, myocarditis,
pericarditis, acute pulmonary edema, gastrointestinal symp-
toms (nausea, vomiting and diarrhea), metabolic acidosis,
congestive heart failure and acute kidney failure. Moreover,
retrosternal pain, shortness of breath, cyanosis, liver fail-
ure, severe hypoglycemia, delirium and tonic-colonic seizure
may occur (12).
Currently, there is no known specific antidote for phosphine
gas poisoning; so a high mortality rate (range 37 to 100%)
is seen among people who are poisoned with it (5). The
treatment for ZnP poisoning is supportive and symptomatic.
There is a controversy regarding use of activated charcoal,
but it is recommended to give a dose of it to the patient on
admission as soon as possible (13). When standard conserva-
tive treatment fails, the only option to save the life of a ZnP-
poisioned patient with irreversible acute liver failure is liver
transplantation (14). Some reports have shown the benefits
of using NAC in patients with hepatic damage due to phos-
phine poisoning, so we treated our patient with NAC (15).
Jaundice due to hepatic damage or intravascular hemolysis
may also occur in organophosphorus toxicity (16, 17). In
our patient, after 3 days of admission, jaundice started and
developed due to intravascular hemolysis and acute hepatic
failure as evident through indirect hyperbilirubinemia, ele-
vated liver enzymes, reticulocytosis, hemolytic anemia, and
the presence of schistocyte in peripheral blood smear. In
some cases, hemolysis occurs due to G6PD deficiency but in
our case, G6PD level was normal (18, 19). Our patient had de-
nied exposure to any other drug, including hemolytic agents,
and had not received any such drug during his hospital stay.
In one study, morphological changes in erythrocytes were re-
ported following in vitro incubation with PH3 gas. However,
all cells displayed crenation, and no hemolysis or Heinz body
formation was noted, thus it is unlikely that hemolysis can be
related to the direct effect of PH3 on the red blood cells (20).
Our patient initially came to emergency ward with gastroin-
testinal symptoms (nausea and vomiting), decreased level of
consciousness, and metabolic acidosis. We observed him
and started conservative therapy. After 3 days, intravascu-
lar hemolysis and liver failure were initiated. We continued
supportive care until his liver enzymes became normal and
hemolysis was stopped.
4. Conclusion:
In patients poisoned with ZnP, jaundice may occur due to
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